King Edward Memorial Hospital
Perth, Western Australia, 6008, Australia
NCT Number: NCT01283854
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and has serious health implications for both the pregnant woman and her child. In particular, offspring of mothers with GDM have an increased prevalence of obesity, diabetes and metabolic syndrome, perpetuating serious health consequences in subsequent generations.
Although regular exercise offers numerous benefits for both the mother and her child, its effectiveness in preventing GDM remains to be established. It has been recently shown that regular supervised home-based exercise may attenuate the decline in glucose tolerance in obese pregnant women. This study aims to conduct a single-centred, multi-sited, single-blinded randomised controlled trial examining the effect of 14 weeks of supervised home-based exercise (commenced at 14 weeks gestation) on the recurrence and severity of GDM, along with other aspects of maternal and fetal wellbeing.
Eligible participants (n = 200) will be randomly allocated to an exercise intervention (n = 100) or a control group (n = 100). The exercise intervention will involve three 60-minute home-based, supervised exercise sessions each week. This type of program overcomes many of the barriers to exercise in this population including transportation, child care issues and embarrassment associated with exercising in a public venue. The investigators have already shown this program to be both feasible and warmly accepted by obese pregnant women.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Perth, Western Australia, 6008, Australia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each participant randomised to the exercise group will be required to participate in three 60-minute exercise sessions each week, starting at 14 weeks gestation, for a total of 14 weeks (i.e. to be completed by 28 weeks of gestation). All exercise sessions will be home-based and fully supervised by an experienced exercise physiologist. The exercise program will be implemented in accordance with the American College of Sports Medicine and the American College of Obstetrics and Gynecology guidelines. All sessions will be conducted on a stationary cycle ergometer.
Heart rate will be measured continuously during exercise to ensure that the exercise intensity is maintained as prescribed. In addition, blood pressure and rate of perceived exertion will be monitored at 10-min intervals. Perceived exertion will not be allowed to exceed a rating of 14 (i.e. "somewhat hard").
Time frame: After the 14 week intervention period (28 weeks gestation)
Time frame: Pre and post-intervention (14 and 28 weeks of gestation)
Time frame: Pre and post-intervention (14 and 28 weeks gestation)
Time frame: Pre and post-intervention (14 and 28 weeks gestation)
Time frame: Pre and post-intervention (14 and 28 weeks gestation)
Time frame: At time of delivery (approximately 40 weeks gestation)
The University of Western Australia
Other
Preventing Gestational Diabetes Mellitus Using a Home-based Supervised Exercise Program During Pregnancy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06431997
Behavior, Behavior, Animal
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05852054
Cardiovascular Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial DetailsNCT01329016
Diabetes Mellitus, Diabetes, Gestational
Indianapolis, Indiana, United States
View Trial DetailsNCT03023293
Allergic Diseases, Behavior
Guangzhou, Guangdong, China
View Trial Details